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Background: MicroRNA (miRNA) are small non-coding RNA molecules which function as nucleic acid-based
specificity factors in the universal RNA binding complex known as the RNA induced silencing complex (RISC). In the
canonical gene-silencing pathway, these activated RISC particles are associated with RNA decay and gene
suppression, however, there is evidence to suggest that in some circumstances they may also stabilise their target
RNA and even enhance translation. To further explore the role of miRNA in this context, we performed a
genome-wide expression analysis to investigate the molecular consequences of bidirectional modulation of the
disease-associated miRNAs miR-181b and miR-107 in multiple human cell lines.
Results: This data was subjected to pathways analysis and correlated against miRNA targets predicted through
seed region homology. This revealed a large number of both conserved and non-conserved miRNA target genes, a
selection of which were functionally validated through reporter gene assays. Contrary to expectation we also
identified a significant proportion of predicted target genes with both conserved and non-conserved recognition
elements that were positively correlated with the modulated miRNA. Finally, a large proportion of miR-181b
associated genes devoid of the corresponding miRNA recognition element, were enriched with binding motifs for
the E2F1 transcription factor, which is encoded by a miR-181b target gene.
Conclusions: These findings suggest that miRNA regulate target genes directly through interactions with both
conserved and non-conserved target recognition elements, and can lead to both a decrease and increase in
transcript abundance. They also multiply their influence through interaction with transcription factor genes
exemplified by the observed miR-181b/E2F1 relationship.
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MicroRNA (miRNA) encompass a highly conserved
class of endogenous small non-coding RNA which
function as the nucleic acid-based specificity factor in
post-transcriptional gene silencing (PTGS) [1-3]. In this
process miRNA direct a ribonucleoprotein effector
complex, known as the RISC, to complementary
miRNA recognition elements (MREs) within the 30
untranslated region (30-UTR) of mRNA transcripts. In
animals these MREs are only partially complementary to
the miRNA, with binding to only the miRNA 'seed
sequence' - spanning bases 2–7 from its 50 end - sufficient* Correspondence: murray.cairns@newcastle.edu.au
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reproduction in any medium, provided the orto mediate PTGS. Due to the redundancy inherent with
partial recognition, each miRNA is estimated to target at
least 200 genes, to the effect that more than 60% of the
human genome could be regulated by miRNA function
[4-6]. Not surprisingly, miRNA have been implicated in
almost all biological processes including cellular growth,
differentiation, apoptosis, and even neurodevelopmental
processes such as dendritic spine development and syn-
aptic plasticity [7,8].
While the sequence-specificity of PTGS can be effect-
ively predicted in silico using bioinformatic algorithms,
the tolerance for partial complementarity in miRNA-
MRE interactions can be difficult to reconcile and leads
to a relatively high false discovery rate. In an attempt
to counter this, many algorithms such as TargetScan
[9] and miRBase [10] utilise a filter which can limit
predicted MREs to sequences with high levels ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 KEGG pathways analysis of predicted miR-181b target
genes. KEGG pathways analysis of predicted target genes for
miR-181b revealed ten significantly enriched pathways: TGF-beta
signalling (p=0.0023); prostate cancer (p=0.0037); neurodegenerative
diseases (p=0.0061); melanogenesis (p=0.0062); long-term
potentiation (p=0.0070); T-cell receptor signalling (p=0.0087); axon
guidance (p=0.0106); MAPK signalling (p=0.0217); dorso-ventral axis
formation (p=0.0236); and circadian rhythms (p=0.0410). MAPK:
mitogen-activated protein kinase. Predicted target genes for
miR-181b were generated from the miRGen database and submitted
for pathways analysis to DAVID.
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of disregarding MREs that may be specific to particular
species or those that have evolved more recently. An
additional filter is also often applied to the interpret-
ation of expression data through the assumption that
miRNA-mRNA interactions are associated with a re-
duction in target stability and steady state transcript
levels. While this relationship is supported at both the
protein [11-13] and RNA [14-16] level, and more re-
cently in experiments investigating both mRNA target
levels and their translation [17], there may be alterna-
tive modalities for some RISC associated transcripts,
beyond gene suppression, that could give rise to
discrete functions during development, particularly in
highly specialized cells such as neurons. This hypothesis
is supported by reports of miRNA stabilising their
mRNA targets and even positively regulating gene
expression [18-21]. More recently a mechanism for
positive transcript regulation though miRNA-mRNA
interactions was proposed [22] whereby, one miRNA
target is modulated in response to the expression of an-
other by acting as a miRNA sponge. The existence of
these competing endogenous RNA (ceRNA) and their
influence on miRNA is supported in a number of recent
studies [23-26].
In view of these and other possible influences of
miRNA on the transcriptome, we established a genome-
wide survey of miRNA-associated target-transcript
abundance to determine the genomic response to bidir-
ectional modulation of miR-181b and miR-107, both of
which have previously been reported to be upregulated
in schizophrenia [27,28]. This provided the means to in-
vestigate the biology of these miRNA in a number of
mammalian cell lines, without assumptions about
miRNA binding and mechanism of action. This revealed
important regulatory roles for miR-181b in the regula-
tion of the cell cycle, differentiation, and neurodevelop-
mental processes; and provided support for alternative
RISC function, where miRNA-mRNA interactions lead
to increases in transcript abundance in addition to the
well-documented silencing-associated decrease.
Results
Predicted miR-181b target genes and functional annotation
The miR-181b predicted target genes were determined
using multiple search algorithms in the miRGen data-
base. Functional significance of miR-181b was inferred
from pathways analysis of its predicted target genes
using the DAVID bioinformatics functional annotation
tool (Figure 1). This approach revealed ten significantly
enriched pathways (p<0.05), including TGF-beta signal-
ling, neurodegenerative diseases, long-term potentiation,
axon guidance, MAPK signalling, and dorso-ventral axis
formation (see Additional file 1: Tables S2–S6 for allmiR-181b enriched KEGG pathways analyses, p-values,
and associated genes).
Biological processes affected by increased miR-181b
expression in cell culture
Cells were transfected with synthetic miR-181b, resulting
in a substantial 288-, 165-, and 11.3-fold increase in
miR-181b expression in HEK-293, HeLa, and SH-SY5Y
cells respectively (Figure 2B). Whole-genome expression
analysis was subsequently performed to identify genes
altered in the presence of increased intracellular miR-
181b concentrations (Figure 2C). In HEK-293 cells this
approach identified 3798 differentially expressed genes
and eight significantly enriched gene pathways (KEGG),
including haematopoietic cell lineage, cell adhesion
molecules, and the calcium signalling pathway. Similarly
in HeLa cells, 3976 genes and nine significantly enriched
pathways were identified, including MAPK signalling
and extracellular matrix interaction. In SH-SY5Y cells,
1492 genes and four pathways were significantly
enriched, including the ATP binding cassette transporter
pathway. Interestingly, neuroactive ligand-receptor inter-
action and cytokine-cytokine receptor interaction were
significantly enriched in all three cell types (Figure 2D).
Figure 2 Biological processes affected by miR-181b over-expression in cell culture via miR-181b transfection. Panel A demonstrates the
experimental design for the identification of genes subject to PTGS by increased miRNA concentrations. Canonical miRNA function results in a
subsequent decrease in mRNA expression levels detected by whole-genome expression analysis using microarrays. These differentially expressed
genes are subsequently utilised for DAVID pathways analysis and correlated against predicted miRNA targets. Panel B shows the increase in miR-
181b expression levels in comparison to controls for HEK-293, HeLa and SH-SY5Y cell types. Panel C shows a clustered-by-gene heat map from
whole genome expression microarray data from each cell model, with n=2 per condition. Panel D shows the significantly enriched KEGG
pathways for each cell type in response to increased intracellular miR-181b levels. RI: receptor interaction; ECM: extracellular matrix; MAPK:
mitogen-activated protein kinase.
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cell culture
Cells were transfected with a sequence-specific antisense
inhibitor of miR-181b (anti-miR-181b) causing a de-
crease in the intracellular concentration of miR-181b in
the order of 2.2-, 11.6-, and 1.4-fold in HEK-293 cells,
HeLa cells, and SH-SY5Y cells respectively (Figure 3B).
To characterise the change in mRNA transcript abun-
dance in response to this reduction of endogenous miR-
181b, we again used whole genome expression array
analysis (Figure 3C). This approach identified 2905 dif-
ferentially expressed genes and ten significantly enriched
gene pathways (KEGG) in HEK-293 cells, while nine
pathways were identified in both HeLa and SH-SY5Ycells, along with 2600 and 1782 differentially expressed
genes, respectively. The MAPK signalling pathway was
significantly enriched in all three cell types, while five
pathways were significantly enriched in two of the three
cell types, including neuroactive ligand-receptor inter-
action and haematopoietic cell lineage (Figure 3D).
Biological processes enriched after bidirectional
modulation of miR-181b expression
For a more stringent appraisal of genes and processes
influenced by miR-181b expression, we examined genes
both downregulated in response to miR-181b over-
expression and upregulated by inhibition of endogenous
miR-181b using the anti-miR inhibitor. This revealed
Figure 3 Biological processes affected by inhibition of endogenous miR-181b in cell culture in response to anti-miR-181b transfection.
Panel A illustrates the experimental design for the identification of genes subject to de-repression of PTGS by decreased endogenous miRNA
concentrations. Genes elevated in response to a fall in miRNA were utilised for pathways analysis and correlated against predicted miRNA targets.
Panel B shows the decrease in miR-181b expression levels in comparison to controls for HEK-293, HeLa and SH-SY5Y cell types. Panel C shows a
clustered-by-gene heat map from whole genome expression microarray data from each cell model, with n=2 per condition. Panel D shows the
significantly enriched KEGG pathways for each cell type in response to decreased intracellular miR-181b levels.
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HEK-293, HeLa, and SH-SY5Ycells respectively (Figure 4).
KEGG pathways analysis on these genes revealed a
statistically significant enrichment of genes involved in
neuroactive ligand-receptor interaction and Fc epsilon
receptor I signalling in HEK-293 cells; and MAPK signal-
ling and taste transduction in HeLa cells. No significantly
enriched pathways were identified in SH-SY5Y cells.
To identify target genes common to each cell type, our
analysis was expanded to genes modulated by either
miR-181b over-expression or inhibition. In doing so, we
observed 620 genes altered across all three cell types,
with six significantly enriched pathways: haematopoiesis,
cytokine-cytokine receptor interaction, melanoma devel-
opment, MAPK signalling, cell adhesion molecules, and
regulation of actin cytoskeleton.Correlation between miRNA–associated gene expression
and target prediction
Comparison of miRNA over-expression and inhibition
To further investigate observed changes in response to
miRNA modulation, the Targetscan algorithm was used
as a framework to measure various prediction para-
meters. In comparing our biological results with Targets-
can’s predictions, a criterion of accuracy was calculated
to determine the proportion of genes correctly predicted
to respond as either targets or non-targets (Figure 5A).
Repeated measures ANOVA (rmANOVA) revealed a
significant difference in accuracy between models of
miRNA over-expression; inhibition; and bidirectional
modulation (p<0.0001). Bidirectional modulation pro-
vided the greatest average accuracy across each cell
type for Targetscan’s various prediction parameters of
Figure 4 Analyses of bidirectionally modulated genes in multiple cell types. The intersection of bidirectionally-modulated genes identifies
genes modulated by both increased miR-181b expression (miR treatment) and miR-181b inhibition (anti-miR-181b treatment) in each cell type.
Genes modulated by either miR-181b over-expression or inhibition were considered for the union of modulated genes across multiple cell types.
The subsequent KEGG pathways analyses on these genes of interest revealed significantly enriched pathways, as evident in the bottom half of
this figure.
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than miR-181b inhibition (77.6%, p<0.0001); which
was in turn significantly higher than miR-181b over-
expression (74.7%, p=0.0006).
The false-positive discovery rate (FPR) was also calcu-
lated to indicate the proportion of predicted targets that
were not differentially expressed in response to miRNA
modulation (Figure 5B). This was significantly different
(rmANOVA) for miRNA over-expression, inhibition,
and bidirectional modulation across each cell type and
prediction parameter (p=0.0046). In a similar fashion,
the false-negative discovery rate (FNR) was calculated to
determine the proportion of genes that were differen-
tially expressed upon modulation of miRNA expression,
despite not being predicted by Targetscan to be regu-
lated by miR-181b (Figure 5B). While this may include
genes differentially expressed by non-miRNA influences
as a result of the transfection process, it can also give an
indication of genes that may be influenced secondary to
miRNA function, downstream in a signalling pathway
from a gene that is a direct miRNA target. There was
also a significant difference between the mean FNR for
miR-181b over-expression, inhibition, and bidirectional
approaches (p=0.0067), with average FNRs for miRNA
inhibition and bidirectional modulation (0.77) signifi-
cantly lower than for miRNA over-expression (p<0.009).Influence of cell lineage
The prediction-response accuracy to miRNA modulation
was significantly different in different cell types (rmA-
NOVA, p<0.0001) (Figure 5A). The SH-SY5Y cell type
provided the greatest accuracy (79.8%); significantly
higher across Targetscan’s various prediction parameters
of conservation and seed region than HeLa (77.1%,
p=0.0049) and HEK-293 (77.0%, p<0.0001) cells. There
was no significant difference in accuracy between HEK-
293 and HeLa cells; these data sets were highly similar
with a correlation coefficient of 0.997 (p<0.0001). There
was also no significant difference in the FNR (p=0.6143)
or FPR (p=0.1630) between cell types (Figure 5B).
Influence of seed region
To explore the influence of seed region composition in
the prediction of observed changes upon miRNA modula-
tion, Targetscan’s non-conserved predictions were cate-
gorised by their length and composition of seed region
(Figure 5A and B). The 8mer seed sequence classification
demonstrated the greatest prediction-response accuracy
(83.4%); significantly higher on average across all experi-
mental parameters than 7mer-1A (78.6%, p<0.0001);
which itself predicted significantly better than the 7mer-
m8 region (71.7%, p<0.0001). For FPRs, the 8mer seed re-
gion offered the lowest FPR (0.11); significantly lower than
Figure 5 The performance of conserved and non-conserved target predictions across multiple biological datasets. Panel A illustrates the
accuracy with which modulated genes were correctly predicted as either targets or non-targets by Targetscan. Error bars were calculated using
the mean, N, and standard deviation across HEK-293, HeLa, and SH-SY5Y datasets. Panel B illustrates the false discovery rates associated with
Targetscan’s prediction of genes modulated subsequent to altered miRNA expression. A false negative indicates a gene differentially expressed
with miRNA modulation, but not a predicted miR-181b target; and a false positive indicates a predicted miR-181b target that is not differentially
expressed with miRNA modulation. Error bars were calculated using the mean, N, and standard deviation across HEK-293, HeLa, and SH-SY5Y
datasets. Panel C shows the conservation status of predicted target genes modulated in response to altered miR-181b expression. The values in
this figure represent the average values across both miR-181b over-expression and inhibition in HEK-293, HeLa, and SH-SY5Y cell types. PCT:
Probability of conserved targeting; the lower the probabilistic value, the poorer the conservation of the predicted binding site across multiple
species.
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Figure 6 Reporter gene analysis of miRNA recognition
elements (MRE). Putative MREs from genes modulated by miRNA
expression were cloned into the 30-UTR of the firefly luciferase gene
in pMIR-REPORT. Responsiveness of the firefly luciferase reporter
gene to increased miR-181b expression (miR-181b transfection) was
analysed with respect to a pRL-TK renilla luciferase control. Data was
normalised against mutant miR-181b miRNA control transfection.
This data was obtained from n=4 experiments, each performed in
triplicate, and analysed using a one-tailed T-test.
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lower than 7mer-m8 (0.25, p<0.0001). Accordingly, the
FNR of the 8mer seed (0.87) was significantly higher than
7mer-1A (0.80, p<0.0001), which was in turn significantly
higher than 7mer-m8 (0.70, p<0.0001).
Influence of target sequence conservation
In each cell condition, the predicted miR-181b target-
response accuracy was significantly improved from 65.5%
to 90.5% (p<0.0001) when excluding non-conserved tar-
gets from these analyses and considering only conserved
targets (Figure 5A). While this was reflected in a substan-
tial decrease in FPR from 0.32 to 0.03 (p<0.0001), it was
also accompanied by an even greater increase in FNR
from 0.63 to 0.97 (p<0.0001) (Figure 5B). The influence
of conservation on the FNR was highlighted by the ob-
servation that on average 81% of modulated genes had
a probability of conserved targeting score (PCT) of less
than 0.1 (Figure 5C; Additional file 2: Figure S1).
Validation of MREs identified in differentially expressed
target genes
Genes sensitive to both increased and decreased miRNA
expression in multiple cell lines were scanned for potential
miR-181b MREs using the miRanda shell script. A selection
of these sites were then cloned downstream of a luciferase
reporter gene construct and their interactions with miR-
181b examined in transfected cells using a dual luciferase
reporter gene assay. This identified 14 novel miR-181b
MREs within 11 genes (p<0.05): BCL2-interacting killer
(apoptosis-inducing) (BIK); cholinergic receptor, nicotinic,
alpha 2 (neuronal) (CHRNA2); disrupted in schizophrenia
1 (DISC1); enkurin (ENKUR/c10orf63); fibrinogen alpha
chain (FGA), G protein-coupled receptor 78 (GPR78); po-
tassium large conductance calcium-activated channel,
subfamily M, beta member 2 (KCNMB2); matrix metallo-
peptidase 14 (membrane-inserted) (MMP14); myotubu-
larin related protein 1 (MTMR1); nuclear receptor
subfamily 6, group A, member 1 (NR6A1); and solute car-
rier family 22 (organic anion transporter), member 7
(SLC22A7) (Figure 6; Table 1).
Investigation of modulated genes devoid of miR-181b MREs
To investigate the potential influence of transcription fac-
tors in differentially expressed genes devoid of miR-181b
binding sites, we analysed their transcription factor
motif composition using the TRANSFAC database. This
revealed a consistent and highly significant enrichment
of genes containing recognition signatures for several
core transcription factors across each condition and cell
type, including E2F transcription factor 1 (E2F1), the ETS
domain transcription factors E74-like factor 1 (ELF1) and
ETS-like gene 1 (ELK1), and the early growth response
(KROX) transcription factor family; all of which possessmiR-181b predicted binding sites. The E2F transcription
factor 1 (E2F1) was particularly significant with multiple
predicted miR-181b MREs and repeated enrichment of
E2F1 transcription factor recognition signatures across
multiple conditions (Additional file 3: Figure S2).
To investigate the possibility that miR-181b is regulat-
ing E2F1 in these cells, a reporter gene containing the
E2F1 30-UTR was co-transfected with miR-181b or its
anti-miR inhibitor (Figure 7). As expected we observed a
significant (p<0.0001) miR-181b associated change in
luciferase activity, however, the direction was contrary to
expectation with a 52% increase in E2F1 reporter gene
expression in response to miR-181b over-expression. To
confirm that this response was not a reporter gene arte-
fact, other E2F1 targeting miRNA miR-107 and miR-20a
were also transfected and analysed. These both produced
more conventional inversely proportional relationships
with the miR-107 inhibition elevating reporter expres-
sion 37% (p<0.0001). Similarly, miR-20a over-expression
caused 50% suppression (p<0.0001) while miR-20a inhib-
ition produced a 22% increase (p=0.0009). This demon-
strates that miR-181b has the capacity to modulate E2F1
expression through it’s 30-UTR, and suggests a mechan-
ism to explain miR-181b associated changes in genes
lacking a corresponding MRE.
Bidirectionally modulated genes are enriched with miR-
181b and E2F1 binding sites
While a large proportion of miR-181b associated changes
can be attributed to the presence of corresponding MREs
Table 1 miR-181b luciferase assay MRE validation
Gene Fold change p-value MRE
BIK −10.38% 0.0187 ATTCCGAGGAGCAGGAGTGCTC
CHRNA2 −6.54% 0.0482 CACTGGCTGGAGAGCAACGTGGATGCC
DISC1 −8.55% 0.0370 TCTAGTTCATTAAAAGTGAATGTT
ENKUR_1 −9.10% 0.0014 CCTTAATGAATAAAGTAATGGATCGTA
ENKUR_2 −8.33% 0.0010 CATCGCTAAGTAAGCAACTTAAGTTGCTT
FGA_1 −20.19% 0.0225 TCCACTAGACGTTGTAATGCACACT
FGA_2 −9.24% 0.0025 TTTGATCCAGCAAAGAATGGATGGATC
GPR78 −17.25% 0.0032 GACGCCCAAAGCAGGATGTGTCTT
KCNMB2 −60.23% <0.0001 CATTACCTGTGAGCTGACTGAATGTT
MTMR1 −18.45% 0.0496 CCCCTGGCTGACTAGGACTGTT
MMP14 −16.68% 0.0490 CCCACCCAGCCCACCCATTGAAGTCT
NR6A1_1 −18.27% 0.0152 TTCACGACAGAGTTGAATGTAT
NR6A1_2 −14.68% 0.0180 ACCAGCTGAGCAGAATGCCATGTT
SLC22A7 −9.38% 0.0392 CACCCTGCAGGGCAATGCATGTC
Carroll et al. BMC Genomics 2012, 13:561 Page 8 of 19
http://www.biomedcentral.com/1471-2164/13/561or E2F1 binding motifs (52% in HEK-293 and HeLa cells;
70% in SH-SY5Y cells), this proportion increases signifi-
cantly to over 80% in HEK-293 and HeLa cells when
only bidirectionally modulated genes are considered
(Additional file 4: Figure S3). Further stringency of this
prediction could also be attained by restricting the analysis
to genes changed by both miR-181b over-expression and
inhibition in two or more cell types, with miR-181b MREs
alone accounting for 48% of differentially expressed genes,
and MRE plus E2F1 motifs covering 84% (Figure 8C1).
Positively correlated miRNA-mRNA interactions
While the transcripts of miRNA target genes are gener-
ally expected to be reduced by their correspondingFigure 7 miRNA-mediated regulation of E2F1 30-UTR reporter
gene expression. The sensitivity of the E2F1 30-UTR to intracellular
181b, miR-107, and miR-20a levels was determined by luciferase
reporter gene expression in the presence of either synthetic miRNA
or corresponding anti-miR inhibitor. In each case the response was
normalised against the respective miRNA and anti-miR control
oligos. This data was obtained from n=4 experiments, each
performed in triplicate.miRNA and display an inverse relationship, it is pos-
sible that some interactions, exemplified by our E2F1
reporter gene, may not display this behaviour. To
explore this possibility further we investigated genes dis-
playing a positive miRNA-mRNA correlation rather
than the canonical negative miRNA-mRNA correlation.
Interestingly, we observed very similar statistics for both
types of interactions with regards to the relationship be-
tween gene expression and target prediction for the dir-
ection of miR-181b modulation; cell lineage; target
conservation; and seed sequence (Figure 8B; Table 2).
The only parameter not representing a significant paral-
lel between canonical and non-canonical response was
the FNR for conserved targets, though a paired student’s
t-test reveals no significant difference (p=0.76). More-
over, predicted miR-181b and E2F1 function for both
canonical and non-canonical responses was also highly
correlated (R2: 0.990, p<0.0001) in classifying the con-
tribution to the gene expression profile across all con-
ditions. Again, more stringent analysis of genes
modulated in multiple conditions and cell types was
characterised by an increase in the proportion of
observed changes that can be attributed to primary and
downstream miR-181b activity (Figure 8C2; Additional
file 4: Figure S3).
Genome-wide analysis of miR-107 associated gene
expression
To further investigate the influence of miRNA on the
transcriptome, we also investigated the bidirectional
modulation of miR-107 in HEK-293 and HeLa cells
(Additional file 5: Figure S4; Additional file 1: Tables S7–
S10). Overall, the gene expression analysis of canonical
miR-107 function demonstrated great consistency with
miR-181b in respect to prediction-response evaluation
Figure 8 Comparison of canonical (left) and non-canonical (right) miRNA-mRNA relationship. Panel A, scheme. Panel B contains charts of
accuracy and false discovery rates associated with Targetscan’s prediction of observed changes in mRNA expression. Panel C, pie charts
illustrating the distribution of miR-181b and E2F1 target genes predicted using different algorithms and parameters in multiple cell types. Signal-
to-noise ratio is shown to increase for both canonical and non-canonical function as stringency increases from genes modulated by either miR-
181b over-expression or inhibition across at least two cell types; to genes modulated by either miR-181b over-expression or inhibition across all
three cell types; to genes modulated by both miR-181b over-expression and inhibition across at least two cell types. Panel D contains charts of
enriched KEGG pathways from genes modulated by either miR-181b over-expression or inhibition across at least two cell types. RI: receptor
interaction. MAPK: mitogen-activated protein kinase.
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also a significant difference (p=0.0002) in the accuracy
of the algorithm to predict the observed changes in
gene expression for miR-107 over-expression, inhibition,
and bidirectional conditions. In both HEK-293 andHeLa cell types, bidirectionally modulated genes pro-
vided the greatest accuracy, significantly higher than
miRNA inhibition (p=0.0015); which was in turn signifi-
cantly higher than miRNA over-expression (p=0.0006).
The FPR was significantly lower in miRNA inhibition
Table 2 Summary of miR-181b correlation analyses for canonical and non-canonical miRNA-mRNA outcomes
Accuracy FPR FNR
miR Modulation
miR R2: 0.995; p<0.0001 R2: 1.000; p<0.0001 R2: 0.976; p<0.0001
anti-miR R2: 0.994; p<0.0001 R2: 1.000; p<0.0001 R2: 0.985; p<0.0001
Bidirectional R2: 1.000; p<0.0001 R2: 1.000; p<0.0001 R2: 0.970; p<0.0001
Cell Type
HEK-293 R2: 0.996, p<0.0001 R2: 1.000, p<0.0001 R2: 0.988, p<0.0001
HeLa R2: 0.996, p<0.0001 R2: 1.000, p<0.0001 R2: 0.983, p<0.0001
SH-SY5Y R2: 1.000, p<0.0001 R2: 1.000, p<0.0001 R2: 0.989, p<0.0001
Conservation
Conserved R2: 0.986, p<0.0001 R2: 0.751, p=0.0196 R2: 0.193, p=0.6183
Non-Conserved R2: 0.959, p<0.0001 R2: 0887, p=0.0014 R2: 0.835, p=0.0051
Seed Sequence
8mer R2: 0.981, p<0.0001 R2: 0.803, p=0.0091 R2: 0.803, p=0.0092
7mer-m8 R2: 0.970, p<0.0001 R2: 0.853, p=0.0034 R2: 0.790, p=0.0112
7mer-1A R2: 0.975, p<0.0001 R2: 0.780, p=0.0131 R2: 0.782, p=0.0127
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turn significantly lower than for miRNA over-expression
(p=0.0013). The FNR was lowest with bidirectional
modulation, followed by miRNA inhibition (p=0.0042),
with miR-107 over-expression providing the highest
FNR (p=0.0009).
Whilst there was no significant difference in the accur-
acy between HEK-293 and HeLa cell types (p=0.1268),
the FPR (p=0.0202) and FNR (p=0.0095) for HEK-293
cells were significantly lower than in HeLa cells. In
considering conservation parameters, Targetscan’s con-
served parameter showed a significantly greater accuracy
than non-conserved (p<0.0001); also providing a signifi-
cantly lower FPR (p<0.0001) and higher FNR (p=0.0002).
Furthermore, of the predicted targets sub-classified
according to seed region, 8mer offered the greatest ac-
curacy, significantly higher than 7mer-m8 (p<0.0001),
which was in turn higher than 7mer-1A (p<0.0001); FPR
was significantly lowest for 8mer (p<0.0001), followed
by 7mer-1A, with 7mer-m8 yielding the highest FPR
(p<0.0001); conversely, the FNR was significantly higher
in 8mer than 7mer-m8 (p=0.0002), which was in turn
significantly higher than the 7mer-1A (p=0.0013) seed
region. With miR-107 also possessing the capacity to
regulate E2F1 expression, the proportion of observed
changes that can be attributed to primary and second-
ary miR-107 function were also investigated, explaining
87% of bidirectionally modulated genes in both cell
types (Figure 9C1; Additional file 4: Figure S3).
Non-canonical miR-107 interactions were also investi-
gated and compared with conventional interactions
(Figure 9; Table 3). As with miR-181b, the only parameter
not to show significant correlation between canonicaland non-canonical miR-107 function is for Targetscan’s
conserved parameter, in which the FPR and FNR were
not significantly correlated, despite no significant differ-
ence between these features by t-test (FPR: p=0.7441;
FNR: p=0.7222). All remaining parameters for analysis
demonstrated highly significant correlation between ca-
nonical and non-canonical miR-107 function (Table 3).
Furthermore, investigating miR-107 and E2F1 predicted
function to explain genomic changes in the non-canonical
direction revealed a highly significant correlation be-
tween canonical and non-canonical responses (R2: 0.994,
p<0.0001) across all miRNA modulation conditions.
Again, combining multiple conditions provided a more
accurate prediction of observed responses, with 81%
of genes bidirectionally modulated in both cell types
(Figure 9C2; Additional file 4: Figure S3).Functional annotation of non-canonical miRNA-mRNA
interactions
A comparative pathways analysis was performed to in-
vestigate the functional characteristics between genes
exhibiting canonical (negative miRNA-mRNA correlation)
and non-canonical (positive miRNA-mRNA positive
correlation) responses across all three cell types subse-
quent to miR-181b modulation (Figure 8D). Genes with
a canonical response were significantly enriched in
haematopoietic cell lineage, cytokine-cytokine receptor
interaction, and MAPK signalling; whereas those dis-
playing a non-canonical response were significantly
enriched in the neuroactive ligand-receptor interaction
and adherens junctions pathways. This comparative ana-
lysis was also applied to the miR-107 dataset to identify
Figure 9 Comparison of canonical (left) and non-canonical (right) miR-107 function. Figure legend as per Figure 8 except in respect to
miR-107.
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cell types (Figure 9D), with canonical function showing
an enrichment in pathways including tight junction,
arrhythmogenic right ventricular cardiomyopathy, path-
ways in cancer, MAPK signalling, and haematopoietic
cell lineage; whilst non-canonical function revealed en-
richment in pathways including neuroactive ligand re-
ceptor interaction, hypertrophic cardiomyopathy, MAPK
signalling, T cell receptor signalling, pathways in cancer,
axon guidance, and the mTOR signalling pathway.Discussion
In this investigation we considered four key epistemic
concepts essential to understanding miRNA function.
Firstly, we theorised that the function of a miRNA is
more than the sum of its targets, and factored into our
investigation the potential for miRNA target gene regu-
lation to produce secondary effects downstream from
the direct target, and that such effects constitute an im-
portant contribution to the biological function of the
miRNA. Secondly, we considered the notion that the
Table 3 Summary of miR-107 correlation analyses for canonical and non-canonical miRNA-mRNA outcomes
Accuracy FPR FNR
miR Modulation
miR R2: 1.000, p<0.0001 R2: 1.000, p<0.0001 R2: 0.997, p<0.0001
anti-miR R2: 0.996, p<0.0001 R2: 1.000, p<0.0001 R2: 0.999, p<0.0001
Bidirectional R2: 1.000, p<0.0001 R2: 1.000, p<0.0001 R2: 0.992, p<0.0001
Cell Type
HEK-293 R2: 0.999, p<0.0001 R2: 1.000, p<0.0001 R2: 0.998, p<0.0001
HeLa R2: 0.999, p<0.0001 R2: 1.000, p<0.0001 R2: 0.997, p<0.0001
Conservation
Conserved R2: 0.990, p=0.0002 R2: 0.675, p=0.1417 R2: 0.519, p=0.2919
Non-Conserved R2: 0.990, p=0.0001 R2: 0.976, p=0.0008 R2: 0.980, p=0.0006
Seed Sequence
8mer R2: 0.993, p<0.0001 R2: 0.875, p=0.0224 R2: 0.955, p=0.0030
7mer-m8 R2: 0.994, p<0.0001 R2: 0.968, p=0.0016 R2: 0.980, p=0.0006
7mer-1A R2: 0.996, p<0.0001 R2: 0.971, p=0.0012 R2: 0.980, p=0.0006
Carroll et al. BMC Genomics 2012, 13:561 Page 12 of 19
http://www.biomedcentral.com/1471-2164/13/561biology of a miRNA is influenced by its expression, and
sought to bidirectionally modulate miRNA levels to gain
insight into miRNA function at both endogenous levels
and under conditions of increased expression. The third
consideration was to investigate miRNA function in
multiple cell types to gain insight into how specific
cellular environments may influence the profile of
genes a specific miRNA may or may not have the ca-
pacity to influence. Finally, rather than considering
miRNA as direct mediators of gene silencing, we
adopted an ontological perspective of miRNA as
sequence-specificity guides for protein complexes to in
turn regulate gene expression. As such, we objectively
investigated both negative and positive miRNA-mRNA
expression patterns and evaluated this against an
established target prediction framework to gain a more
complete understanding of miRNA function.
miR-181b functions as a complex regulator of cell cycle
progression and differentiation
There is an ever-increasing body of evidence linking
miRNA-mediated gene dysregulation to various patho-
physiological processes. However, apart from a select
number of validated miRNA target genes – considering
each miRNA is predicted to regulate potentially hun-
dreds of target genes – the biological function of miRNA
in different cellular environments is poorly understood
due to their vast functional pleiotropy. This is exempli-
fied by miR-181b which has been shown to be asso-
ciated with schizophrenia [28]; muscle development
[29]; haematopoiesis [30-33]; and a variety of cancers,
both as an oncogene [34-43] and a tumour suppressor
[44-49]. In this study we employed an empirical ge-
nomics approach to miRNA target analysis through
the generation of bidirectional transfection models inHeLa, HEK-293 and SH-SY5Y cell types. Genes differ-
entially expressed in response to elevation or repres-
sion of miRNA expression were used to define the
biology of the miRNA and ascertain both primary tar-
get genes and their downstream effects.
We observed a large number of genes in the haemato-
poietic cell lineage pathway that were differentially
expressed with increased intracellular miR-181b concen-
trations in HEK-293 cells, suggesting that genes within
the haematopoietic pathway can be regulated by miR-
181b when this miRNA is over-expressed in this cell
line; as well as by endogenous miR-181b concentrations
in both HEK-293 and SH-SY5Y cells. This supports the
strong and repeated association of miR-181b and haem-
atopoiesis previously reported in the literature, with tar-
gets including the murine Bcl-2, CD69 and the T-cell
receptor [32], along with the chemokine [C-X-C motif]
receptor 4 (CXCR4) [33].
In each cell type we also observed a repeated enrich-
ment of modulated genes involved in various pathways
associated with oncogenesis. Firstly, the inhibition of
miR-181b function revealed an enrichment of modulated
genes in the MAPK signalling pathway for HEK-293,
HeLa and SH-SY5Y cells, suggesting that endogenous
miR-181b – directly or indirectly – regulates this critical
cell-cycle signalling pathway in each of these cell types;
pathways analysis revealed that only in HeLa cells did
miR-181b appear to have the capacity to extend its
regulation on this signalling pathway at higher miRNA
concentrations. Further to this, we observed an enrich-
ment of modulated genes involved in cytokine-cytokine
receptor interaction by endogenous miR-181b levels in
SH-SY5Y cells, and by increased miRNA concentrations
in HEK-293 and HeLa cells. In the latter of the two cell
types, increased miR-181b levels also saw the modulation
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miRNA expression was associated with regulating path-
ways involved in endometrial cancer, focal adhesion, and
extracellular-matrix interaction. A complex association
of both positive and negative regulation of oncogenic
processes was also suggested by the identification of a
miR-181b MRE within the pro-apoptotic protein BIK
[50], as well as a highly-conserved MRE in the tumour
invasion factor MMP14 [51,52]. Both of these interac-
tions were supported by reporter gene assay. Similarly a
conserved miR-181b MRE was also identified in
MTMR1, previously identified as an important regulator
of myogenesis through its association with muscular dis-
orders such as myotubular myopathy and congenital
myotonic dystrophy [53,54], though its exact biological
role is still unclear [54]. Positive regulation of myogenesis
has also been supported by miR-181b suppression of
HOXA11 and a HOXA11 reporter gene [29].
Importantly, we observed a consistent and significant
enrichment of the neuroactive ligand-receptor inter-
action pathway across all three cell types treated with
miR-181b, in addition to its enrichment in both
HEK-293 and SH-SY5Y cells treated with anti-miR-181b.
This was further supported by the validation of miR-181b
MREs within the 30-UTRs of the schizophrenia suscepti-
bility genes DISC1 [55-57], ENKUR [58] and GPR78
[59], as well as the nicotinic acetylcholine receptor
CHRNA2, and the potent binding site in KCNMB2,
involved in controlling neuronal excitability by function-
ing as a subunit in large conductance voltage and cal-
cium−activated potassium channels – also known as BK,
MaxiK, or Slo channels [60,61]. These interactions have
significant implications for schizophrenia as miR-181b
has been shown to be altered in the disorder [27,28].
These results, in addition to the literature, indicate a
key role for miR-181b in the fine-tuning of expression
levels of numerous functionally related genes in specific
signalling pathways. The collective biological influence,
while different in the various cell types, appeared to con-
verge in regulation of the cell cycle, differentiation states,
and neurodevelopmental processes.
Reconciling miRNA-associated gene expression with
predicted function
While the biological activity of miRNA are complex,
the ability to predict their interactions with target mRNA
provides important insight into the diverse functions of
these molecules. However, these predictions are prone to
both substantial under and over-prediction depending on
the stringency, and usually fail to account for the local in-
fluence of other miRNA, RNA binding proteins and
RNA secondary structure, and are incapable of determin-
ing downstream effects. To investigate the power and
limitations of target prediction we compared miR-181bassociated genes in vitro with conserved and non-
conserved targets predicted by Targetscan. Interestingly,
only a relatively small proportion (av. 3.46%) of respon-
sive genes contained conserved 30-UTR motifs, com-
pared to the significantly larger proportion (av. 34.94%)
which had non-conserved miRNA recognition elements.
While the conserved target predictions had a lower false
positive rate, they displayed a very high rate of false nega-
tives; whereas the inclusion of non-conserved targets
provided a substantial improvement in the false negative
rate, with some cost in terms of an increase in the false
positive discovery rate. This suggests that despite their
recent emergence, in an evolutionary context, many
non-conserved miRNA elements are likely to exert a sig-
nificant influence on their host gene.
The seed sequence composition was also reflected in
the prediction rate, with the 8mer seed region providing
the greatest predictive power for observed changes for
each miRNA. The variation observed for the 7mer-1A
and 7mer-m8 seed regions between miR-181b and miR-
107 supports the notion that determinants for target rec-
ognition exist outside of the seed region [62], while also
highlighting the increased false-positive rate associated
with non-conserved target predictions. The biological
relevance of these predictions is indicated by the
increased proportion of biological changes explained
through primary and secondary miRNA function when
considering only those genes modulated across multiple
conditions and cell types, thereby supporting the adop-
tion of a broad approach in biological modelling of
miRNA function. With respect to in silico modelling of
miRNA function, it may also be more prudent to accept
some degree of over-prediction associated with the ac-
quisition of non-conserved targets genes rather than a
more conservative approach using only conserved tar-
gets, which appear to be associated with an unacceptably
high level of under-prediction.
Collectively modulated genes with predicted miR-181b
MREs, both conserved and non-conserved, still only
accounted for a proportion (av. 38.59%) of all miR-
responsive genes. Significantly, many of these genes lack-
ing predicted MREs for miR-181b contained binding
motifs for the E2F1 transcription factor (av. 30.74%).
This suggests that miR-181b, predicted to bind to mul-
tiple MREs within the 30-UTR of E2F1, is able to indir-
ectly influence E2F1-regulated genes as a secondary
consequence of E2F1’s own regulation by miR-181b.
Surprisingly, E2F1 30-UTR luciferase reporter gene ex-
pression was shown to be elevated in the presence of
its cognate miRNA, rather than being repressed in ac-
cordance with the canonical PTGS mechanism. Despite
the unexpected direction of this response, it neverthe-
less provides a means for this downstream influence
observed in response to miR-181b modulation. While
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the potential to exert a downstream influence, these
should be limited by the relatively short time frame of
this experiment (24 hours). In addition to this influence,
there is also a range of other mechanisms that may
underlie the discrepancy between observed and pre-
dicted miR-181b response. For example, alternative poly-
adenylation and splicing often produces tissue-specific
30-UTR variants [63,64], such that specific gene isoforms
may contain or exclude MREs for miR-181b. Moreover
up to 40% of currently-predicted miRNA target elements
reside in regions which may not always be part of
the mature mRNA transcript [65]. MREs outside the
30-UTR, such as the coding regions or even 50-UTRs
[66], are also thought to have some capacity for miRNA
mediated gene silencing [67]. Either way, while these
genes may not constitute direct targets of miR-181b,
they are still significant to understanding its function in
the context of specific biological environments.
miRNA suppression compared with miRNA
overexpression
In this study we found that inhibition of endogenous
miRNA using anti-miR transfection yielded gene expres-
sion changes that reflected all target prediction variables
more favourably than miRNA over-expression. This sug-
gests that the subtle modification of physiological levels
of endogenous miRNA leads to more significant and
biologically indicative changes in target gene expression
than the supra-physiological expression induced by syn-
thetic miRNA. One possibility is that target genes are
already approaching saturation with endogenously
synthesised molecules and there is only a small pool of
free targets that become associated with transfected
miRNA. Another possibility is that exogenously deliv-
ered miRNA compete with endogenous miRNA for
RISC association and cause some distortion of the over-
all gene silencing profile by repressing the function of
endogenous miRNA. Interestingly, we also observed ele-
vation of differentially expressed genes with E2F1 motifs
after miR-181b over-expression.
Support for non-canonical miRNA function
miRNA-mRNA interactions are generally thought to re-
sult in gene silencing by reducing the stability and trans-
lation of RISC-associated mRNA. However, there are
some reports to suggest that this is not always the case
with miRNA also being capable of protecting or even
elevating the steady state levels of their RISC-associated
transcripts. In support of this hypothesis we identified a
substantial group of predicted miRNA target genes
which displayed positive correlation with the intracellu-
lar miRNA rather than the expected or canonical, in-
versely proportional response. These target genesdisplayed the same properties as the negatively corre-
lated targets including their dependency on the direction
of miRNA modulation, cellular background, and conser-
vation; in addition to the differential response to pre-
dicted seed threshold paring; as well as contributions to
secondary effects through predicted E2F1 function; and
increased accuracy of target prediction when analysing
only genes modulated in multiple treatment/cell type
combinations. These observations were also replicated
for miR-107 expression profiling, all displaying highly
significant correlation between observed canonical and
non-canonical responses.
This highly consistent correlation of miRNA target
prediction for both canonical and non-canonical miRNA
function suggests that there are functionally significant
alternative fates for miRNA-associated mRNA. One pos-
sibility is that some RISC-associated miRNA/mRNA
may be involved more in post-transcriptional trafficking
and/or translational silencing, and as a consequence the
steady state levels of both molecules are correlated as the
mRNA is protected or sequestered through its association
with miRNA and other ribonuclear proteins within intra-
cellular compartments. This form of translational control
may be important for complex highly-differentiated cells.
For example, neurons may have subcellular ribonuclear
protein structures that can support this form of func-
tional partitioning that may give rise to these positively
correlated interactions [68], and it is therefore interesting
that pathways associated with non-canonical target gene
response tended to be more enriched for neuronal path-
ways than canonical function. While the mechanism and
features that mark this kind of relationship are yet to be
determined, by characterising the genes, miRNA and cell
types involved, we may get a clearer picture of the under-
lying molecular biology. In one hypothesis, miRNA
themselves may be the targets of other miRNA and hence
the increase of one miRNA may cause a net increase
in gene expression because of its repression of another
miRNA targeting the same genes. In this respect, miR-
181b has been shown to negatively regulate let-7 ex-
pression [69]. Our analysis of this effect did not reveal
enrichment of predicted let-7 MREs between genes dem-
onstrating negative and positive miRNA-mRNA correl-
ation for miR-181b. Further evidence of this phenomenon
in miR-107 datasets suggests this behaviour extends be-
yond let-7-miR-181b feedback.
Previous investigation of positively-acting miRNA
suggest that this feature may be attributed to a cell
cycle-dependent switch between translation activation
and repression: at certain stages of the cell cycle let-7
was shown to switch from repressor to activator [18],
with increased mRNA levels attributed to miRNA bind-
ing at AU-rich elements (ARE): elements that promote
mRNA degradation. However, an investigation into the
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tively versus negatively correlated genes, and the ARE in
the 3-UTR of E2F1 neither overlaps the binding sites for
miR-181b, -107 or -20a.
Conclusions
In summary, gene expression profiling was used to iden-
tify the molecular influence of miRNA and evaluate the
fate of associated target transcripts. This revealed that a
large proportion of target genes are not conserved and
that many genes are modified by miRNA-associated sec-
ondary influence, exemplified by the relationship be-
tween miR-181b E2F1 transcription factor and genes
with E2F1 motifs. The analysis of positively associated
target genes also suggested that a substantial proportion
of miRNA associated mRNA are not destabilised and
degraded. Rather, they may be protected and display
some alternative cellular function. This hypothesis was
supported by the divergence of pathways enriched with
target genes that are positively correlated with the
miRNA compared to the canonical negatively correlated
relationship. We suspect that these miRNA-mRNA rela-
tionships and the alternative fates of the transcript are
important for complex cellular functions, particularly in
neurons, and hence warrant further investigation.
Methods
Cell culture and modulation of miRNA expression
HeLa, HEK-293 and SH-SY5Y cell lines were maintained
as confluent monolayers at 37°C with 5% CO2 and 90%
humidity in Dulbecco’s Modified Eagle Medium (DMEM)
with 10% (vol/vol) foetal bovine serum (Bovagen), 20mM
HEPES (4-(2-hydroxyethyl) piperazine-1-ethanesulfonic
acid) and 2mM L-glutamine. miRNA expression was
modulated in cultured cells in vitro using synthetic
miRNA or LNA-modified anti-miR oligonucleotides
(see Additional file 1: Table S1 for all oligonucleotide
sequences). In each case, these oligos were delivered
by either transfection or electroporation as described
previously [70,71]. HeLa and HEK-293 cells were seeded
in 10cm petri dishes at 5 × 106 cells/well, and transfected
24hrs later using Lipofectamine 2000 (Invitrogen) accord-
ing to manufacturer’s instructions. SH-SY5Y cultures (1 ×
106 cells) were subjected to electroporation using Nucleo-
fector Kit V according to the manufacturer’s protocol
(Amaxa). All cell lines were transfected with either 100nM
siRNA or 250nM LNA-anti-miR oligos, with HEK-293
and HeLa cells compared against their non-transfection
controls, and SH-SY5Y cells against an siRNA control
targeting the enhanced green fluorescent protein (EGFP).
Gene expression microarray analysis
Total RNA was extracted from cultured cells 24-hours
post-transfection using TRIzol reagent (Invitrogen), andquantitative real-time RT-PCR performed as previously
described [72] to validate successful modulation of
miRNA expression from the transfection experiments.
The extracted RNA was prepared for gene expression
analysis using an RNeasy MinElute cleanup kit (Qiagen),
followed by biotin-labelling RNA amplification with
the TotalPrep RNA amplification kit (Ambion). The la-
belled RNA was subsequently hybridised to Illumina
HumanRef-8 whole-genome expression BeadChips, and
scanned using an Illumina BeadArray Reader. RNA con-
centration was measured using a Quant-iT RiboGreen
RNA assay kit and Qubit fluorometer (Invitrogen). All
procedures were performed according to manufacturer’s
instructions. Data was obtained using Beadstudio v3.2,
and analysed using GeneSpring GX 7.3.1.
Default settings in GeneSpring were utilised to execute
both per gene and per chip normalisation, as well as to
generate gene- and condition-based hierarchical cluster-
ing. Genes were excluded from analyses if their expres-
sion was below-background in more than half of the
samples for each cell line. Gene expression levels in con-
trol treatment samples were measured as a reference
point for differential gene expression analysis. Genes
were considered differentially expressed if changed by
more than 1.5-fold in response to modulation of miRNA
expression. For the purpose of exploratory analysis, all
genes with a p<0.05 (non-corrected) were considered.
For pathways analysis of more restricted gene sets con-
sistent through bidirectional modulation of miRNA, we
reduced the threshold further to include genes on the
basis of fold change alone.
Bioinformatic analyses
The functional annotation tool of the Database for
Annotation, Visualization, and Integrated Discovery
(DAVID) bioinformatics resource [73] (http://david.abcc.
ncifcrf.gov/) was used to analyse target genes of interest,
whether predicted and/or identified from differential
gene expression analysis, and used to identify signifi-
cantly enriched KEGG pathways against a homo sapiens
background. Venn Diagrams were generated using
Venny [74].
miRNA target predictions were downloaded from
TargetScan Human Release 5.2, with predicted target
genes for miR-181b and miR-107 categorised by cross-
species conservation and seed-region composition before
being correlated against the observed gene expression
changes subsequent to miRNA modulation. Seed region
composition was defined as follows: “8mer” have an ‘A’
at position 1 and perfect complimentary from positions
2–8 of the mature miRNA; “7mer-m8” have perfect
complementarity from positions 2–8 of the mature
miRNA; and “7mer-1A” have an ‘A’ at position 1 and
perfect complementarity to positions 2–7 of the mature
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get gene that was differentially expressed in the direction
for canonical miRNA function; ‘true negatives’ were
those genes not predicted as miRNA targets and not dif-
ferentially expressed; a ‘false positive’ was a gene pre-
dicted to be a miRNA target, but not differentially
expressed with miRNA modulation; and ‘false negatives’
were those genes not predicted to be miRNA targets but
differentially expressed in the direction corresponding to
canonical miRNA function. Targets from miRGen [75]
were also included where specified. Subsequent analysis
of non-canonical miRNA function was carried out as
described above. Canonical miRNA function was defined
with respect to the conventional expectation of an in-
verse relationship between miRNA and mRNA expres-
sion, whereas non-canonical miRNA function was
defined as the positive correlation observed between
miRNA and mRNA expression levels.
The accuracy of the Targetscan algorithm to predict
observed biological changes was determined by the sum
of all ‘true positive’ and ‘true negative’ observations as a
percentage of all ‘true positive’, ‘true negative’, ‘false posi-
tive’, and ‘false negative’ observations. The sensitivity was
determined by calculating the number of ‘true positives’
divided by the number of ‘true positives’ and ‘false nega-
tives’, thus giving an indication of the proportion of
observed changes that were predicted correctly by the
algorithm. This is represented as a value between zero
and one, with a high sensitivity indicating a low ‘false
negative’ rate (FNR); the FNR (Type II error) is calcu-
lated as [1-sensitivity]. Specificity was calculated as the
number of ‘true negatives’ divided by the sum of ‘true
negatives’ and ‘false positives’. This is represented as a
value between zero and one, with a high specificity
indicating a low ‘false positive’ rate (FPR); the FPR
(Type I error) is calculated as [1-specificity]. Statistical
analyses were performed using GraphPad Prism 5,
where repeated measures ANOVAs (rmANOVAs) and
Student’s t-tests (paired, two-tailed) were performed to
investigate differences between various parameters, whilst
correlation was used to investigate similarities between
parameters of canonical and non-canonical responses.
The TRANSFAC [76] function of GATHER [77]
(http://gather.genome.duke.edu/) was used to identify
enrichment of specific transcription factor signatures
within differentially expressed genes. A Bayes Factor of 6,
which in each case corresponded to a p-value <0.0001,
was used as a threshold for statistical significance. AU-rich
elements were identified using the Organism function
of the ARE database (http://brp.kfshrc.edu.sa/AredOrg/)
[78]. Potential MREs in genes of interest were identified
using miRanda v1.0 software [79], with 30-UTR infor-
mation obtained using AceView [80]. Genes associated
with schizophrenia were selected from the SchizophreniaGene Database Index (http://www.schizophreniaforum.
org/res/sczgene/dbindex.asp).
miRNA target-gene reporter assays
Putative miR-181b MREs containing synthetic sequences
were cloned into Spe I and Hind III sites in the multiple
cloning region downstream of the firefly luciferase gene
in pMIR-REPORT (Ambion) backbone as described
[27,28,71]. To achieve this, 4μg pMIR-REPORT was
incubated for two hours at 37°C with 2U each Spe I and
Hind III, 10U of T4 DNA ligase, and 10μM of double-
stranded DNA oligonucleotide of potential miR-181b
recognition element.
Validation of putative MREs was performed using
the dual luciferase reporter gene assay (Promega) in a
96-well format, with 4x104 cells seeded per well. Lipo-
fectamine 2000 was used to transfect SH-SY5Y cells
24 hours post-seeding, with 1.33nM synthetic miRNA
co-transfected along with 2ng recombinant pMIR-
REPORT firefly luciferase reporter gene construct, and
12ng pRL-TK renilla luciferase vector as an internal trans-
fection control. The response of recombinant 30-UTR
motifs to miR-181b was normalised with respect to a
mutant miR-181b control (miR-181b_mut, designed
from the miR-181b backbone with mutations introduced
at positions 3, 5, and 7; see Additional file 1: Table S1
for oligonucleotide sequences). For validation of miRNA
interaction with E2F1, 50ng E2F1 30-UTR reporter
(Switchgear Genomics) was co-transfected into HEK-293
cells with 15ng pRL-TK and either 30nM miRNA or
100nM anti-miR inhibitor. For each miRNA and anti-
miR inhibitor, reporter gene expression was normalised
against miR-26b and anti-miR-16_scr4 oligonucleotide
controls respectively, designed and selected due to their
minimal predicted binding across the entirety of the
E2F1 30-UTR. For each condition, experiments were
performed n=4 times, each with internal triplicates (to
generate mean data values), and a paired t-test per-
formed to compare responses between treatment and
control oligos.
Additional files
Additional file 1: Supplementary Tables. Contains supplementary
tables S1–S10. This includes sequence information for all oligonucleotides
used in this study, along with enriched KEGG pathways, p-values, and
contributing genes for experimental conditions in each cell type.
Additional file 2: Figure S1. Conservation scores for modulated
predicted miR-181b targets, as predicted using Targetscan. PCT:
Probability of conserved targeting; the lower the probabilistic value, the
poorer the conservation of the predicted binding site across multiple
species. Bidirectional 2+ indicates genes modulated by both miR-181b
over-expression and inhibition across two or more cell models.
Additional file 3: Figure S2. Bioinformatic evidence for a role of E2F1
transcription factor in contributing to miRNA-associated expression
profiles. Panel A graphically represents the Transcription factor association
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inhibition in HEK-293, HeLa, and SH-SY5Y cell models. The TRANSFAC
function of GATHER was used to identify significantly enriched
transcription factor signatures within modulated genes. A Bayes factor of
6 was used for threshold significance, which in each case corresponded
to p<0.0001. Panel B illustrates predicted binding sites for schizophrenia-
associated miR-181b, miR-107, and miR-20a in the 30-UTR of E2F1, as well
as the AU-rich element in this 30-UTR. These predicted binding sites were
identified using the miRanda shell algorithm; only sites with threshold
scores greater than 120 are shown in this figure.
Additional file 4: Figure S3. Distribution of predicted miRNA and E2F1
function for modulated mRNA. Panel A shows the proportion of
modulated genes that can be attributed to predicted miR-181b and E2F1
function across individual and multiple cell models; whilst Panel B shows
this for miR-107 predicted function. In both panels data is presented for
canonical (negative miRNA-mRNA correlation) and non-canonical
(positive miRNA-mRNA correlation) patterns of correlation. Differentially
expressed genes are classified as being predicted in preferential fashion
by: Targetscan conserved predicted miR-181b target; Targetscan non-
conserved predicted miR-181b target, with PCT (probability of
conservation) scores <0.1; Targetscan non-conserved predicted miR-181b
target, with PCT scores >0.1; not predicted as a miR-181b target by
Targetscan, but predicted by the miRGen algorithm; predicted as
containing E2F1 recognition signatures using the TRANSFAC algorithm.
Additional file 5: Figure S4. Bidirectional modulation of miR-107
expression. Panel A shows enriched KEGG pathways from predicted miR-
107 target genes. Panel B shows the modulation of miR-107 expression
levels in HEK-293 and HeLa cell types, indicative of miR-107 over-
expression and inhibition. Panel C illustrates enriched KEGG pathways
from modulated mRNA subsequent to miR-107 over-expression in HEK-
293 and HeLa cell models. Panel D illustrates enriched KEGG pathways
from modulated mRNA subsequent to miR-107 inhibition in HEK-293 and
HeLa cell models. Panel E shows Venn diagrams and subsequent KEGG
pathways analyses for the intersection of bidirectionally modulated genes
in each cell type; and for the union of modulated genes across multiple
cell models. The intersection of bidirectionally-modulated genes identifies
genes modulated by both miR-107 over-expression and inhibition in
each cell type. Genes modulated by either over-expression or inhibition
were considered for the union of modulated genes across multiple cell
types. The subsequent KEGG pathways analyses on these genes of
interest revealed significantly enriched pathways, as evident in the
bottom half of this panel. R-M: Receptor-mediated. RI: receptor
interaction. ECM: Extracellular matrix. ARVC: Arrhythmogenic right
ventricular cardiomyopathy.
Abbreviations
miRNA: microRNA; RISC: RNA induced silencing complex; E2F1: E2F
transcription factor 1; MRE: miRNA recognition element; 30: UTR: 30
untranslated region; ceRNA: Competing endogenous RNA; LNA: Locked-
nucleic acid; rmANOVA: Repeated measures analysis of variance; FPR: False
positive discovery rate; FNR: False negative discovery rate; PCT: Probability of
conserved targeting; ARE: AU-rich element.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
APC contributed to the design of this study, developed the experimental
techniques and carried out this study, analysed and interpreted the data,
and wrote the manuscript. NT contributed to the study design. PAT provided
technical assistance and contributed to the manuscript preparation. MJC
conceived the initial study design, participated in its design and
implementation, and co-wrote the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
This work was supported by the Schizophrenia Research Institute utilising
infrastructure funding from New South Wales Ministry of Health. Funding
support was also provided through a National Alliance for Research onSchizophrenia and Depression (NARSAD) Young Investigator Award (MC); a
National Health and Medical Research Council Project Grant (631057); a
Hunter Medical Research Institute grant and an M.C. Ainsworth Research
Fellowship in Epigenetics (MC). The pRL-TK vector was kindly provided by
Charles de Bock (University of Newcastle, Australia).
Author details
1School of Biomedical Sciences and Pharmacy, Faculty of Health and Hunter
Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia.
2Schizophrenia Research Institute, Darlinghurst, NSW, Australia. 3School
Medical and Molecular Biosciences. Faculty of Science, University of
Technology, Sydney, NSW, Australia. 4Centre for Health Technologies, Faculty
of Engineering and Information Technology, University of Technology,
Sydney, Australia.
Received: 15 June 2012 Accepted: 12 October 2012
Published: 19 October 2012
References
1. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T: Identification of
novel genes coding for small expressed RNAs. Science 2001,
294(5543):853–858.
2. Lau NC, Lim LP, Weinstein EG, Bartel DP: An abundant class of tiny RNAs
with probable regulatory roles in Caenorhabditis elegans. Science 2001,
294(5543):858–862.
3. Lee RC, Ambros V: An extensive class of small RNAs in Caenorhabditis
elegans. Science 2001, 294(5543):862–864.
4. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by
adenosines, indicates that thousands of human genes are microRNA
targets. Cell 2005, 120(1):15–20.
5. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, Lander ES,
Kellis M: Systematic discovery of regulatory motifs in human promoters
and 30 UTRs by comparison of several mammals. Nature 2005,
434(7031):338–345.
6. Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mRNAs are
conserved targets of microRNAs. Genome Res 2009, 19(1):92–105.
7. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, Greenberg
ME: A brain-specific microRNA regulates dendritic spine development.
Nature 2006, 439(7074):283–289.
8. Ashraf SI, McLoon AL, Sclarsic SM, Kunes S: Synaptic protein synthesis
associated with memory is regulated by the RISC pathway in Drosophila.
Cell 2006, 124(1):191–205.
9. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB: Prediction of
mammalian microRNA targets. Cell 2003, 115(7):787–798.
10. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ:
miRBase: microRNA sequences, targets and gene nomenclature. Nucleic
Acids Res 2006, 34(Database issue):D140–144.
11. Petersen CP, Bordeleau ME, Pelletier J, Sharp PA: Short RNAs repress
translation after initiation in mammalian cells. Mol Cell 2006,
21(4):533–542.
12. Olsen PH, Ambros V: The lin-4 regulatory RNA controls developmental
timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis
after the initiation of translation. Dev Biol 1999, 216(2):671–680.
13. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E, Bertrand
E, Filipowicz W: Inhibition of translational initiation by Let-7 MicroRNA in
human cells. Science 2005, 309(5740):1573–1576.
14. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE:
Regulation by let-7 and lin-4 miRNAs results in target mRNA
degradation. Cell 2005, 122(4):553–563.
15. Wu L, Fan J, Belasco JG: From the Cover: MicroRNAs direct rapid
deadenylation of mRNA. Proc Natl Acad Sci U S A 2006,
103(11):4034–4039.
16. Behm-Ansmant I, Rehwinkel J, Izaurralde E: MicroRNAs Silence Gene
Expression by Repressing Protein Expression and/or by Promoting
mRNA Decay. Cold Spring Harb Symp Quant Biol 2006, 71:523–530.
17. Guo H, Ingolia NT, Weissman JS, Bartel DP: Mammalian microRNAs
predominantly act to decrease target mRNA levels. Nature 2010,
466(7308):835–840.
18. Vasudevan S, Tong Y, Steitz JA: Switching from repression to activation:
microRNAs can up-regulate translation. Science 2007,
318(5858):1931–1934.
Carroll et al. BMC Genomics 2012, 13:561 Page 18 of 19
http://www.biomedcentral.com/1471-2164/13/56119. Lin CC, Liu LZ, Addison JB, Wonderlin WF, Ivanov AV, Ruppert JM:
A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit
protein translation depending upon cell context. Mol Cell Biol 2011,
31(12):2513–2527.
20. Ghosh T, Soni K, Scaria V, Halimani M, Bhattacharjee C, Pillai B: MicroRNA-
mediated up-regulation of an alternatively polyadenylated variant of the
mouse cytoplasmic {beta}-actin gene. Nucleic Acids Res 2008, 36(19):6318–
6332.
21. Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, Barton DJ, Lemon
SM: Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex.
Proc Natl Acad Sci U S A 2012, 109(3):941–946.
22. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP: A ceRNA hypothesis:
the Rosetta Stone of a hidden RNA language? Cell 2011,
146(3):353–358.
23. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M,
Tramontano A, Bozzoni I: A long noncoding RNA controls muscle
differentiation by functioning as a competing endogenous RNA. Cell
2011, 147(2):358–369.
24. Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, Karreth F, Poliseno L,
Provero P, Di Cunto F, et al: Coding-independent regulation of the tumor
suppressor PTEN by competing endogenous mRNAs. Cell 2011,
147(2):344–357.
25. Sumazin P, Yang X, Chiu HS, Chung WJ, Iyer A, Llobet-Navas D, Rajbhandari
P, Bansal M, Guarnieri P, Silva J, et al: An extensive microRNA-mediated
network of RNA-RNA interactions regulates established oncogenic
pathways in glioblastoma. Cell 2011, 147(2):370–381.
26. Karreth FA, Tay Y, Perna D, Ala U, Tan SM, Rust AG, DeNicola G, Webster KA,
Weiss D, Perez-Mancera PA, et al: In vivo identification of tumor-
suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model
of melanoma. Cell 2011, 147(2):382–395.
27. Beveridge NJ, Gardiner E, Carroll AP, Tooney PA, Cairns MJ: Schizophrenia is
associated with an increase in cortical microRNA biogenesis. Mol
Psychiatry 2010, 15(12):1176–1189.
28. Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, Scott RJ, Tran
N, Dedova I, Cairns MJ: Dysregulation of miRNA 181b in the temporal
cortex in schizophrenia. Hum Mol Genet 2008, 17(8):1156–1168.
29. Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R,
Souidi M, Cuvellier S, Harel-Bellan A: The microRNA miR-181 targets the
homeobox protein Hox-A11 during mammalian myoblast differentiation.
Nat Cell Biol 2006, 8(3):278–284.
30. de Yebenes VG, Belver L, Pisano DG, Gonzalez S, Villasante A, Croce C, He L:
Ramiro AR: miR-181b negatively regulates activation-induced cytidine
deaminase in B cells. J Exp Med 2008, 205(10):2199–2206.
31. Chen CZ, Li L, Lodish HF, Bartel DP: MicroRNAs modulate hematopoietic
lineage differentiation. Science 2004, 303(5654):83–86.
32. Neilson JR, Zheng GX, Burge CB, Sharp PA: Dynamic regulation of miRNA
expression in ordered stages of cellular development. Genes Dev 2007,
21(5):578–589.
33. Georgantas RW 3rd, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin
GA, Croce CM, Civin CI: CD34+ hematopoietic stem-progenitor cell
microRNA expression and function: a circuit diagram of differentiation
control. Proc Natl Acad Sci U S A 2007, 104(8):2750–2755.
34. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY:
MicroRNA miR-21 overexpression in human breast cancer is associated
with advanced clinical stage, lymph node metastasis and patient poor
prognosis. RNA 2008, 14(11):2348–2360.
35. Boggs RM, Wright ZM, Stickney MJ, Porter WW, Murphy KE: MicroRNA
expression in canine mammary cancer. Mamm Genome 2008,
19(7–8):561–569.
36. Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, Galloni NN, Pintilie
M, Jurisica I, Perez-Ordonez B, Gilbert R, et al: Identification of a microRNA
signature associated with progression of leukoplakia to oral carcinoma.
Hum Mol Genet 2009, 18(24):4818–4829.
37. Nakajima G, Hayashi K, Xi Y, Kudo K, Uchida K, Takasaki K, Yamamoto M, Ju
J: Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated
with Chemoresponse to S-1 in Colon Cancer. Cancer Genomics Proteomics
2006, 3(5):317–324.
38. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen
ST, Chan TL, Kwong DL, Au GK, et al: MicroRNA expression profiles
associated with prognosis and therapeutic outcome in colon
adenocarcinoma. JAMA 2008, 299(4):425–436.39. Yantiss RK, Goodarzi M, Zhou XK, Rennert H, Pirog EC, Banner BF, Chen YT:
Clinical, pathologic, and molecular features of early-onset colorectal
carcinoma. Am J Surg Pathol 2009, 33(4):572–582.
40. Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Chan G, Kamath SG, Chen
DT, Dressman H, Lancaster JM: MicroRNAs and their target messenger
RNAs associated with ovarian cancer response to chemotherapy. Gynecol
Oncol 2009, 113(2):249–255.
41. Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K:
TGFbeta-mediated upregulation of hepatic miR-181b promotes
hepatocarcinogenesis by targeting TIMP3. Oncogene 2010, 29(12):1787–1797.
42. Menghini R, Menini S, Amoruso R, Fiorentino L, Casagrande V, Marzano V,
Tornei F, Bertucci P, Iacobini C, Serino M, et al: Tissue inhibitor of
metalloproteinase 3 deficiency causes hepatic steatosis and adipose
tissue inflammation in mice. Gastroenterology 2009, 136(2):663–672. e664.
43. Wang Y, Yu Y, Tsuyada A, Ren X, Wu X, Stubblefield K, Rankin-Gee EK, Wang
SE: Transforming growth factor-beta regulates the sphere-initiating stem
cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene
2011, 30(12):1470–1480.
44. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller
K, Lein M, Kristiansen G, Jung K: Diagnostic and prognostic implications of
microRNA profiling in prostate carcinoma. Int J Cancer 2009,
126(5):1166–1176.
45. Careccia S, Mainardi S, Pelosi A, Gurtner A, Diverio D, Riccioni R, Testa U,
Pelosi E, Piaggio G, Sacchi A, et al: A restricted signature of miRNAs
distinguishes APL blasts from normal promyelocytes. Oncogene 2009,
28(45):4034–4040.
46. Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A, Wang
H, Sun H, Volinia S, Alder H, et al: MicroRNA gene expression during
retinoic acid-induced differentiation of human acute promyelocytic
leukemia. Oncogene 2007, 26(28):4148–4157.
47. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V,
Volinia S, Alder H, Liu CG, Rassenti L, et al: Tcl1 expression in chronic
lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res
2006, 66(24):11590–11593.
48. Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R, Debey-Pascher S,
Schulz A, Frenzel LP, Claasen J, et al: miRNA deregulation by epigenetic
silencing disrupts suppression of the oncogene PLAG1 in chronic
lymphocytic leukemia. Blood 2009, 114(15):3255–3264.
49. Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, Y Y: hsa-mir-181a and hsa-mir-
181b function as tumor suppressors in human glioma cells. Brain Res
2008, 1236:185–193.
50. Chinnadurai G, Vijayalingam S, Rashmi R: BIK, the founding member of the
BH3-only family proteins: mechanisms of cell death and role in cancer
and pathogenic processes. Oncogene 2008, 27(Suppl 1):S20–29.
51. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A
matrix metalloproteinase expressed on the surface of invasive tumour
cells. Nature 1994, 370(6484):61–65.
52. Itoh Y: MT1-MMP: a key regulator of cell migration in tissue. IUBMB Life
2006, 58(10):589–596.
53. Kim SA, Taylor GS, Torgersen KM, Dixon JE: Myotubularin and MTMR2,
phosphatidylinositol 3-phosphatases mutated in myotubular myopathy
and type 4B Charcot-Marie-Tooth disease. J Biol Chem 2002, 277(6):4526–
4531.
54. Buj-Bello A, Furling D, Tronchere H, Laporte J, Lerouge T, Butler-Browne GS,
Mandel JL: Muscle-specific alternative splicing of myotubularin-related 1
gene is impaired in DM1 muscle cells. Hum Mol Genet 2002,
11(19):2297–2307.
55. Thomson PA, Wray NR, Millar JK, Evans KL, Hellard SL, Condie A, Muir WJ,
Blackwood DH, Porteous DJ: Association between the TRAX/DISC locus
and both bipolar disorder and schizophrenia in the Scottish population.
Mol Psychiatry 2005, 10(7):657–668. 616.
56. Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR,
Verchinski BA, Meyer-Lindenberg A, Balkissoon R, Kolachana B, et al:
Variation in DISC1 affects hippocampal structure and function and
increases risk for schizophrenia. Proc Natl Acad Sci U S A 2005,
102(24):8627–8632.
57. Cannon TD, Hennah W, van Erp TG, Thompson PM, Lonnqvist J, Huttunen
M, Gasperoni T, Tuulio-Henriksson A, Pirkola T, Toga AW, et al: Association
of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray
matter, and impaired short- and long-term memory. Arch Gen Psychiatry
2005, 62(11):1205–1213.
Carroll et al. BMC Genomics 2012, 13:561 Page 19 of 19
http://www.biomedcentral.com/1471-2164/13/56158. Schwab SG, Knapp M, Sklar P, Eckstein GN, Sewekow C, Borrmann-
Hassenbach M, Albus M, Becker T, Hallmayer JF, Lerer B, et al: Evidence for
association of DNA sequence variants in the phosphatidylinositol-4-
phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia. Mol
Psychiatry 2006, 11(9):837–846.
59. Underwood SL, Christoforou A, Thomson PA, Wray NR, Tenesa A, Whittaker
J, Adams RA, Le Hellard S, Morris SW, Blackwood DH, et al: Association
analysis of the chromosome 4p-located G protein-coupled receptor 78
(GPR78) gene in bipolar affective disorder and schizophrenia. Mol
Psychiatry 2006, 11(4):384–394.
60. Knaus HG, Schwarzer C, Koch RO, Eberhart A, Kaczorowski GJ, Glossmann H,
Wunder F, Pongs O, Garcia ML, Sperk G: Distribution of high-conductance
Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve
terminals. J Neurosci 1996, 16(3):955–963.
61. Hu H, Shao LR, Chavoshy S, Gu N, Trieb M, Behrens R, Laake P, Pongs O,
Knaus HG, Ottersen OP, et al: Presynaptic Ca2+−activated K+ channels in
glutamatergic hippocampal terminals and their role in spike
repolarization and regulation of transmitter release. J Neurosci 2001,
21(24):9585–9597.
62. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP:
MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed
Pairing. Mol Cell 2007, 27(1):91–105.
63. Black DL: Mechanisms of alternative pre-messenger RNA splicing. Annu
Rev Biochem 2003, 72:291–336.
64. Mignone F, Gissi C, Liuni S, Pesole G: Untranslated regions of mRNAs.
Genome Biol 2002, 3(3):REVIEWS0004.
65. Majoros WH, Ohler U: Spatial preferences of microRNA targets in 30
untranslated regions. BMC Genomics 2007, 8:152.
66. Lytle JR, Yario TA, Steitz JA: Target mRNAs are repressed as efficiently by
microRNA-binding sites in the 50 UTR as in the 30 UTR. Proc Natl Acad Sci
U S A 2007, 104(23):9667–9672.
67. Gu S, Jin L, Zhang F, Sarnow P, Kay MA: Biological basis for restriction of
microRNA targets to the 30 untranslated region in mammalian mRNAs.
Nat Struct Mol Biol 2009, 16(2):144–150.
68. Goldie BJ, Cairns MJ: Post-transcriptional trafficking and regulation of
neuronal gene expression. Mol Neurobiol 2012, 45(1):99–108.
69. Li X, Zhang J, Gao L, McClellan S, Finan MA, Butler TW, Owen LB, Piazza GA,
Xi Y: MiR-181 mediates cell differentiation by interrupting the Lin28 and
let-7 feedback circuit. Cell Death Differ 2011, 19(3):378–386.
70. Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, Stewart GJ, Broadley
S, Scott RJ, Booth DR, Lechner-Scott J: MicroRNAs miR-17 and miR-20a
inhibit T cell activation genes and are under-expressed in MS whole
blood. PLoS One 2010, 5(8):e12132.
71. Beveridge NJ, Tooney PA, Carroll AP, Tran N, Cairns MJ: Down-regulation of
miR-17 family expression in response to retinoic acid induced neuronal
differentiation. Cell Signal 2009, 21(12):1837–1845.
72. Santarelli DM, Beveridge NJ, Tooney PA, Cairns MJ: Upregulation of dicer
and microRNA expression in the dorsolateral prefrontal cortex
Brodmann area 46 in schizophrenia. Biol Psychiatry 2011, 69(2):180–187.
73. Sherman BT, da Huang W, Tan Q, Guo Y, Bour S, Liu D, Stephens R, Baseler
MW, Lane HC, Lempicki RA: DAVID Knowledgebase: a gene-centered
database integrating heterogeneous gene annotation resources to
facilitate high-throughput gene functional analysis. BMC Bioinformatics
2007, 8:426.
74. VENNY: An interactive tool for comparing lists with Venn Diagrams.
http://bioinfogp.cnb.csic.es/tools/venny/index.html.
75. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG: miRGen: a database
for the study of animal microRNA genomic organization and function.
Nucleic Acids Res 2007, 35(Database issue):D149–D155.
76. Wingender E, Dietze P, Karas H, Knuppel R: TRANSFAC: a database on
transcription factors and their DNA binding sites. Nucleic Acids Res 1996,
24(1):238–241.
77. Chang JT, Nevins JR: GATHER: a systems approach to interpreting
genomic signatures. Bioinformatics 2006, 22(23):2926–2933.78. Halees AS, El-Badrawi R, Khabar KS: ARED Organism: expansion of ARED
reveals AU-rich element cluster variations between human and mouse.
Nucleic Acids Res 2008, 36(Database issue):D137–D140.
79. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS: MicroRNA targets
in Drosophila. Genome Biol 2003, 5(1):R1.
80. Thierry-Mieg D, Thierry-Mieg J: AceView: a comprehensive cDNA-
supported gene and transcripts annotation. Genome Biol 2006,
7(Suppl 1):11–14. S12.
doi:10.1186/1471-2164-13-561
Cite this article as: Carroll et al.: Alternative mRNA fates identified in
microRNA-associated transcriptome analysis. BMC Genomics 2012 13:561.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
